J. E. Rosenberg

Genomic Characterization of Upper Tract Urothelial Carcinoma.

N. Schultz, M. Berger, V. Reuter, 2015, European urology.

Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts

Jianjiong Gao, A. Hakimi, I. Ostrovnaya, 2020, Nature Communications.

Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results.

P. Ascierto, B. Mellado, P. Sharma, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy.

N. Socci, B. Taylor, N. Schultz, 2014, Cancer discovery.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees

S. Culine, A. Horwich, J. Witjes, 2020 .